Micaela M Hernberg

14PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Models of care and place of birthSocio-economic developmentInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 08, 2026
Detection of disease recurrence in real-world patients with completely resected stage III cutaneous melanoma.

|May 11, 2026
A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma.

|Jul 23, 2025
Association of Pretreatment Tumour Microenvironment and Treatment Outcome in Patients With Locally Advanced Melanoma Treated With Isolated Limb Perfusion.

Sanni K A Tulokas, Susanna Juteau, Siru P Mäkelä

|Feb 11, 2025
Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II).

Pia J Heino, Jukka Pappinen, John F Thompson

|Jan 30, 2025
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Eva Kimby, Sämi Schär, Maria Cristina Pirosa

|Aug 25, 2023
Intra-patient evolution of tumor microenvironment in the pathogenesis of treatment-naïve metastatic melanoma patients.

Laura Kohtamäki, Suvi-Katri Leivonen, Siru Mäkelä

Pageof 3

Frequent Collaborators

4 joint publications

Siru P Mäkelä

3 joint publications

Laura Kohtamäki

3 joint publications

Susanna M Juteau

2 joint publications

Kalle Mattila